Literature DB >> 8289341

Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.

G Dong1, T R Broker, L T Chow.   

Abstract

The E6 promoter of human papillomaviruses (HPVs) trophic for epithelia for the lower genital tract and the upper respiratory tract is regulated in vitro by homologous and heterologous papillomaviral E2 proteins that bind to a consensus responsive sequence (E2-RS) ACCN6GGT. When HPV type 11 (HPV-11) expression is examined in epithelial cell lines, the HPV-11 E2-C protein, which lacks the amino-terminal transactivating domain of the full-length E2 protein, invariably represses the homologous viral E6 promoter. In contrast, when the novel constitutive enhancer (CE) CE II is deleted, not only is the basal promoter activity much reduced, it is further repressed by the intact HPV-11 E2 protein (M. T. Chin, T. R. Broker, and L. T. Chow, J. Virol. 63:2967-2976, 1989). Here, we demonstrated that, when expressed from a stronger surrogate promoter, the HPV-11 E2 protein represses the E6 promoter effectively, regardless of CE II. By performing systematic mutational analyses of the four highly conserved copies of the HPV-11 E2-RS and of the adjacent enhancer-promoter elements, we show that the furthest upstream, promoter-distal E2-RS copy 1 plays no apparent role in E6 promoter regulation. Repression by the homologous HPV-11 E2 proteins is mediated through each of the three promoter-proximal copies of the E2-RS, but the presence of CE II abrogates the full-length E2 protein repression exerted at E2-RS copy 2. Repression is alleviated when the two (for E2) or three (for E2-C) promoter-proximal copies of E2-RS are mutated. We specifically demonstrate that repression exerted at E2-RS 3 is due to preclusion of binding of the host transcription factor Sp1 or Sp1-like proteins to a nonconsensus sequence AGGAGG located 1 bp upstream of the tandem E2 protein binding sites 3 and 4. A 3-bp insertion between the adjacent Sp1 and E2-RS 3 sites permits both Sp1 and E2 proteins to bind, with a concomitant relief of E2-RS 3-mediated repression. Similar mutational analyses show that proteins that bind to the GT-1 motif near the upstream E2-RS 2 help abrogate repression by the E2 protein in the presence of CE II. The implications of these results with respect to the viral infectious cycle and during viral oncogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289341      PMCID: PMC236550          DOI: 10.1128/JVI.68.2.1115-1127.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Developmental modulation of protein binding to beta-globin gene regulatory sites within chicken erythrocyte nuclei.

Authors:  P D Jackson; T Evans; J M Nickol; G Felsenfeld
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

2.  The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.

Authors:  N Dostatni; P F Lambert; R Sousa; J Ham; P M Howley; M Yaniv
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

Review 3.  Control of papillomavirus gene expression.

Authors:  R Sousa; N Dostatni; M Yaniv
Journal:  Biochim Biophys Acta       Date:  1990-06-01

4.  The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor.

Authors:  A Stenlund; M R Botchan
Journal:  Genes Dev       Date:  1990-01       Impact factor: 11.361

5.  Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome.

Authors:  R Li; J Knight; G Bream; A Stenlund; M Botchan
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

6.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.

Authors:  H Romanczuk; F Thierry; P M Howley
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1.

Authors:  F Hoppe-Seyler; K Butz; H zur Hausen
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  The constitutively expressed octamer binding protein OTF-1 and a novel octamer binding protein expressed specifically in cervical cells bind to an octamer-related sequence in the human papillomavirus 16 enhancer.

Authors:  C L Dent; G A McIndoe; D S Latchman
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

9.  Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7.

Authors:  M Nasseri; J R Gage; A Lorincz; F O Wettstein
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

10.  Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.

Authors:  T H Haugen; L P Turek; F M Mercurio; T P Cripe; B J Olson; R D Anderson; D Seidl; M Karin; J Schiller
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  71 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

4.  The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

Authors:  M J O'Connor; W Stünkel; C H Koh; H Zimmermann; H U Bernard
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.

Authors:  S Y Hou; S Y Wu; T Zhou; M C Thomas; C M Chiang
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.

Authors:  M G McPhillips; J G Oliveira; J E Spindler; R Mitra; A A McBride
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.

Authors:  Michal-Ruth Schweiger; Matthias Ottinger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

8.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

10.  Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas.

Authors:  T P DiLorenzo; B M Steinberg
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.